[Product] Application of VLP Technology

Effective PCV2 Prevention with CircoGuard V Inj.

'CircoGuardV' is a vaccine that incorporates VLP (Virus-Like Particle) technology through a collaboration with OptiFarm.

Unlike conventional vaccines that neutralize viruses, VLP technology utilizes virussized particles in the nanometer range that closely resemble the virus structure but do not contain the viral genome. These VLPs are administered into the body without causing infection and generate immunity against specific pathogens. Additionally, the manufacturing process of this vaccine minimizes side effects like fever, pain, and swelling, as it does not involve the use of serum and goes through a distinctive refinement process at Green Cross Veterinary Products.

Furthermore, this vaccine uses a selfdeveloped Carbopol adjuvant, enhancing the antigen quantity and simultaneously inducing humoral and cellular immune responses. Field trials conducted by OptiFarm have confirmed that 'CircoGuard-V' demonstrates performance levels on par with multinational company vaccines in terms of reduction in morbidity rate, mortality rate, daily weight gain, and days to market readiness.